Immune to Cancer: The CRI Blog
-
Tecelra® Receives FDA Approval: A New Milestone in Cancer Treatment
On August 2, 2024, the U.S Food and Drug Administration (FDA) approved Tecelra® (afamitresgene autoleucel), a gene… -
ImmunoAdvocate Perspectives: Navigating Cancer Immunotherapy and Survivorship
Sharing one’s cancer survival story is not just a personal act of courage — it has the… -
How Immunotherapy Saved Terry’s Life
Mere days before Christmas in 2014, Terry Weiss was diagnosed with non-small cell lung cancer (NSCLC) after… -
How Immunotherapy Saved Lenny’s Life
Lenny Weiland’s lung cancer survival story is one that can benefit all of us. The New Jersey… -
How Immunotherapy Saved Dan’s Life
Dan Griffith’s life took a dramatic turn when he was diagnosed with non-small cell lung cancer (NSCLC)…. -
How Focused Ultrasound and Immunotherapy Could Transform Cancer Treatment
Recent advancements in cancer treatment are reshaping patient care in multiple ways. Focused ultrasound and cancer immunotherapy… -
How Proteasomes are Changing the Face of Cancer Immunotherapy
Cancer immunotherapy is revolutionizing treatment by harnessing the power of the body’s own immune system to recognize,… -
Immunization Awareness Month: Unlocking the Potential of Cancer Vaccines for a World Immune to Cancer
Disease prevention is an integral part of the collective health of our society. The COVID-19 pandemic was… -
Translating Science into Survival at the 8th Annual CICON Conference
CRI is proud to co-host the eighth annual Cancer Immunotherapy Conference (CICON) alongside the European Network for…
Join CRI in Shaping the Future of Immunotherapy
Support the pioneering work of CRI in advancing immunotherapy.